Investigators report a cumulative 10-year incidence of end-stage kidney disease of 2.5% among patients who undergo surgery for renal cell carcinoma (RCC), which is 10 times higher than in patients without RCC.
In both men and women, nocturia is significantly associated with an increased risk for all-cause and cardiovascular mortality, according to investigators.
Patients with stones smaller than 7 mm are more likely have a successful treatment than those with larger stones, investigators concluded.
Patients who underwent HIFU total ablation of the prostate had a 30-month failure-free survival rate similar to that of patients treated with radical prostatectomy, according to investigators.
Adjuvant chemotherapy prolongs survival among patients with negative surgical margins regardless of number of positive lymph nodes.
A recent study may support use of tamsulosin as medical expulsion therapy following shockwave lithotripsy.
A propensity-score matched comparison revealed no significant difference in oncologic outcomes between radical cystectomy and trimodal therapy.
Cytoreductive partial nephrectomy and robotic radiosurgery appear to have a place in the treatment of metastatic renal cell carcinoma, research findings suggest.
Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.
A final analysis of the TITAN trial shows that apalutamide vs placebo added to ADT significantly lowers the risk of death and castration-resistant disease in men with metastatic castration-sensitive prostate cancer.
Please login or register first to view this content.
